FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition
The Federal Trade Commission has reached a deal with Amgen to allow the company's $27.8 billion purchase of Horizon Therapeutics to proceed, despite initially seeking to block the acquisition due to concerns over competition in the pharmaceutical industry.